GlassScriptPhysician profile
Paul M Joslin
NPI 1073570412
$2,759.40
in general payments reported to CMS, 2019-2025
36 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,211 · 2020: $147 · 2021: $636 · 2022: $497 · 2023: $93.75 · 2024: $58.73 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.30 | 2019-2022 | |
| Novo Nordisk INC | $353.13 | 2019-2022 | |
| Pfizer INC. | $278.22 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $265.86 | 2019-2024 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.68 | 2019-2022 | |
| Amgen INC. | $150.87 | 2019-2025 | Otezla, Repatha |
| Lilly USA, LLC | $129.35 | 2019-2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $100.65 | 2019-2023 | Freestyle Libre 3 |
| Astellas Pharma US INC | $96.02 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $95.47 | 2019-2023 | Rexulti, Abilify Maintena |
| Amarin Pharma, INC. | $70.31 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.74 | 2019-2022 | |
| Glaxosmithkline, LLC. | $50.45 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Gilead Sciences, INC. | $42.20 | 2019-2024 | |
| Genentech USA, INC. | $41.34 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40.08 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $39.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $29.60 | 2019 | |
| Shire North American Group INC | $28.82 | 2019 | |
| Boston Scientific Corporation | $27.67 | 2019-2024 | Watchman Flx |
| Teva Pharmaceuticals USA, INC. | $27.60 | 2021 | |
| Antares Pharma, INC. | $26.55 | 2019 | |
| Merck Sharp & Dohme LLC | $26.36 | 2021 | |
| Nevro Corp. | $25.89 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.66 | 2019 | |
| Recor Medical INC | $21.73 | 2025 | Paradise Ultrasound Renal Denervation System |
| Biohaven Pharmaceutical Holding Company LTD. | $21.00 | 2022 | |
| Ardelyx, INC. | $19.90 | 2025 | Ibsrela |
| Mannkind Corporation | $18.64 | 2022 | |
| Lifescan, INC. | $18.54 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.89 | 2022 | |
| Scynexis, INC. | $14.85 | 2022 | |
| Sunovion Pharmaceuticals INC. | $14.21 | 2021 | |
| Almatica Pharma LLC | $13.96 | 2025 | Loreev Xr, Teriparatide |
| Sanofi-Aventis U.S. LLC | $12.42 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Joslin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.